A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute stemi patients undergoing primary PCI

  • David Adlam
  • , Maciej Zarebinski
  • , Neal G. Uren
  • , Pawel Ptaszynski
  • , Keith G. Oldroyd
  • , Shahzad Munir
  • , Azfar Zaman
  • , Hussain Contractor
  • , Róbert Gábor Kiss
  • , István Édes
  • , Joanna Szachniewicz
  • , Gergely Gyorgy Nagy
  • , Mario J. Garcia
  • , János Tomcsanyi
  • , John Irving
  • , Andrew S. P. Sharp
  • , Piotr Musialek
  • , Géza Lupkovics
  • , Cheerag Shirodaria
  • , Joseph B. Selvanayagam
    • Pauline Quinn, Leong Ng, Mark Roth, Michael A. Insko, Ben Haber, Stephen Hill, Lori Siegel, Simon Tulloch, Keith M. Channon (Lead / Corresponding author)

    Research output: Contribution to journal › Article › peer-review

    13 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute stemi patients undergoing primary PCI'. Together they form a unique fingerprint.

    Keyphrases

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science